22147-Gall Bladder Cancer-NA-1270

Gall Bladder Cancer

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: NA
USOR Number:

  • Address

11750 W 2nd Place, Suite 160
Lakewood, CO 80228
P: (303) 430-2700

Search by practice name, trial titles, indicators and specific disease types.